Profiling Heparan Sulfate Proteoglycans in Ovarian Carcinoma

by Andrew R. Clamp, Gordon C. Jayson
Published 2005-01-01

Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial

by Elizabeth C. James, David Dunn, Adrian D. Cook, Andrew R. Clamp, Matthew R. Sydes
Published 2020-09-01

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer

by Robert D Morgan, Andrew R Clamp, Jurjees Hasan, Gordon C Jayson, Sofia Stamatopoulou, Nerissa Mescallado, Geoff Saunders, Richard Welch, Claire Mitchell
Published 2019-04-01

Discharging Women with Advanced Ovarian Cancer on Home Parenteral Nutrition: Making and Implementing the Decision

by Anne Marie Sowerbutts, Simon Lal, Jana Sremanakova, Andrew R. Clamp, Gordon C. Jayson, Antje Teubner, Lisa Hardy, Chris Todd, Anne-Marie Raftery, Eileen Sutton, Sorrel Burden
Published 2020-01-01

Palliative home parenteral nutrition in patients with ovarian cancer and malignant bowel obstruction: experiences of women and family caregivers

by Anne Marie Sowerbutts, Simon Lal, Jana Sremanakova, Andrew R. Clamp, Gordon C. Jayson, Antje Teubner, Lisa Hardy, Chris Todd, Anne-Marie Raftery, Eileen Sutton, Robert D. Morgan, Alexander J. Vickers, Sorrel Burden
Published 2019-12-01

A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity

by Louisa Nelson, Anthony Tighe, Anya Golder, Samantha Littler, Bjorn Bakker, Daniela Moralli, Syed Murtuza Baker, Ian J. Donaldson, Diana C. J. Spierings, René Wardenaar, Bethanie Neale, George J. Burghel, Brett Winter-Roach, Richard Edmondson, Andrew R. Clamp, Gordon C. Jayson, Sudha Desai, Catherine M. Green, Andy Hayes, Floris Foijer, Robert D. Morgan, Stephen S. Taylor
Published 2020-02-01